nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—Etoposide—urinary bladder cancer	0.0794	0.226	CbGbCtD
Eszopiclone—CYP3A4—Thiotepa—urinary bladder cancer	0.0686	0.195	CbGbCtD
Eszopiclone—CYP2C8—Fluorouracil—urinary bladder cancer	0.0549	0.157	CbGbCtD
Eszopiclone—CYP2C8—Etoposide—urinary bladder cancer	0.0458	0.131	CbGbCtD
Eszopiclone—CYP2C9—Fluorouracil—urinary bladder cancer	0.0383	0.109	CbGbCtD
Eszopiclone—CYP2C9—Cisplatin—urinary bladder cancer	0.0325	0.0927	CbGbCtD
Eszopiclone—CYP3A4—Etoposide—urinary bladder cancer	0.0186	0.053	CbGbCtD
Eszopiclone—CYP3A4—Doxorubicin—urinary bladder cancer	0.0127	0.0361	CbGbCtD
Eszopiclone—CYP2C9—urine—urinary bladder cancer	0.00283	0.114	CbGeAlD
Eszopiclone—CYP3A4—urine—urinary bladder cancer	0.00216	0.0868	CbGeAlD
Eszopiclone—TSPO—prostate gland—urinary bladder cancer	0.00167	0.067	CbGeAlD
Eszopiclone—TSPO—seminal vesicle—urinary bladder cancer	0.00141	0.0567	CbGeAlD
Eszopiclone—TSPO—epithelium—urinary bladder cancer	0.00123	0.0493	CbGeAlD
Eszopiclone—TSPO—smooth muscle tissue—urinary bladder cancer	0.00118	0.0475	CbGeAlD
Eszopiclone—TSPO—renal system—urinary bladder cancer	0.00114	0.0457	CbGeAlD
Eszopiclone—TSPO—urethra—urinary bladder cancer	0.00112	0.0449	CbGeAlD
Eszopiclone—PTGS1—prostate gland—urinary bladder cancer	0.000928	0.0373	CbGeAlD
Eszopiclone—TSPO—female reproductive system—urinary bladder cancer	0.000911	0.0366	CbGeAlD
Eszopiclone—GABRA2—vagina—urinary bladder cancer	0.00089	0.0358	CbGeAlD
Eszopiclone—TSPO—vagina—urinary bladder cancer	0.000824	0.0331	CbGeAlD
Eszopiclone—PTGS1—seminal vesicle—urinary bladder cancer	0.000785	0.0316	CbGeAlD
Eszopiclone—CYP2C8—renal system—urinary bladder cancer	0.00078	0.0314	CbGeAlD
Eszopiclone—PTGS1—epithelium—urinary bladder cancer	0.000682	0.0274	CbGeAlD
Eszopiclone—PTGS1—smooth muscle tissue—urinary bladder cancer	0.000657	0.0264	CbGeAlD
Eszopiclone—PTGS1—renal system—urinary bladder cancer	0.000633	0.0254	CbGeAlD
Eszopiclone—CYP2C8—female reproductive system—urinary bladder cancer	0.000625	0.0251	CbGeAlD
Eszopiclone—GABRA2—lymph node—urinary bladder cancer	0.000576	0.0231	CbGeAlD
Eszopiclone—CYP2C8—vagina—urinary bladder cancer	0.000565	0.0227	CbGeAlD
Eszopiclone—CYP2C9—female reproductive system—urinary bladder cancer	0.000555	0.0223	CbGeAlD
Eszopiclone—TSPO—lymph node—urinary bladder cancer	0.000533	0.0214	CbGeAlD
Eszopiclone—CYP3A4—renal system—urinary bladder cancer	0.000529	0.0212	CbGeAlD
Eszopiclone—PTGS1—female reproductive system—urinary bladder cancer	0.000507	0.0204	CbGeAlD
Eszopiclone—PTGS1—vagina—urinary bladder cancer	0.000458	0.0184	CbGeAlD
Eszopiclone—CYP3A4—female reproductive system—urinary bladder cancer	0.000423	0.017	CbGeAlD
Eszopiclone—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000401	0.000699	CcSEcCtD
Eszopiclone—Sweating—Methotrexate—urinary bladder cancer	0.000396	0.000692	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000396	0.000691	CcSEcCtD
Eszopiclone—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000396	0.000691	CcSEcCtD
Eszopiclone—Paraesthesia—Etoposide—urinary bladder cancer	0.000395	0.00069	CcSEcCtD
Eszopiclone—Weight increased—Epirubicin—urinary bladder cancer	0.000395	0.000689	CcSEcCtD
Eszopiclone—Haematuria—Methotrexate—urinary bladder cancer	0.000394	0.000688	CcSEcCtD
Eszopiclone—Weight decreased—Epirubicin—urinary bladder cancer	0.000393	0.000685	CcSEcCtD
Eszopiclone—Dyspnoea—Etoposide—urinary bladder cancer	0.000393	0.000685	CcSEcCtD
Eszopiclone—Somnolence—Etoposide—urinary bladder cancer	0.000391	0.000683	CcSEcCtD
Eszopiclone—Epistaxis—Methotrexate—urinary bladder cancer	0.00039	0.00068	CcSEcCtD
Eszopiclone—Vomiting—Thiotepa—urinary bladder cancer	0.00039	0.00068	CcSEcCtD
Eszopiclone—Drowsiness—Epirubicin—urinary bladder cancer	0.000387	0.000675	CcSEcCtD
Eszopiclone—Rash—Thiotepa—urinary bladder cancer	0.000386	0.000674	CcSEcCtD
Eszopiclone—Bronchitis—Doxorubicin—urinary bladder cancer	0.000386	0.000674	CcSEcCtD
Eszopiclone—Dermatitis—Thiotepa—urinary bladder cancer	0.000386	0.000674	CcSEcCtD
Eszopiclone—Headache—Thiotepa—urinary bladder cancer	0.000384	0.00067	CcSEcCtD
Eszopiclone—Decreased appetite—Etoposide—urinary bladder cancer	0.000383	0.000668	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00038	0.000663	CcSEcCtD
Eszopiclone—Body temperature increased—Cisplatin—urinary bladder cancer	0.00038	0.000663	CcSEcCtD
Eszopiclone—Fatigue—Etoposide—urinary bladder cancer	0.00038	0.000662	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000379	0.000662	CcSEcCtD
Eszopiclone—Stomatitis—Epirubicin—urinary bladder cancer	0.000377	0.000658	CcSEcCtD
Eszopiclone—Pain—Etoposide—urinary bladder cancer	0.000377	0.000657	CcSEcCtD
Eszopiclone—Constipation—Etoposide—urinary bladder cancer	0.000377	0.000657	CcSEcCtD
Eszopiclone—Conjunctivitis—Epirubicin—urinary bladder cancer	0.000376	0.000656	CcSEcCtD
Eszopiclone—Urinary tract infection—Epirubicin—urinary bladder cancer	0.000376	0.000656	CcSEcCtD
Eszopiclone—Dysuria—Doxorubicin—urinary bladder cancer	0.000376	0.000655	CcSEcCtD
Eszopiclone—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000374	0.000652	CcSEcCtD
Eszopiclone—Hepatitis—Methotrexate—urinary bladder cancer	0.000371	0.000648	CcSEcCtD
Eszopiclone—Sweating—Epirubicin—urinary bladder cancer	0.000371	0.000647	CcSEcCtD
Eszopiclone—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000371	0.000647	CcSEcCtD
Eszopiclone—Asthenia—Gemcitabine—urinary bladder cancer	0.00037	0.000645	CcSEcCtD
Eszopiclone—Haematuria—Epirubicin—urinary bladder cancer	0.000369	0.000644	CcSEcCtD
Eszopiclone—Pharyngitis—Methotrexate—urinary bladder cancer	0.000368	0.000643	CcSEcCtD
Eszopiclone—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000367	0.00064	CcSEcCtD
Eszopiclone—Weight increased—Doxorubicin—urinary bladder cancer	0.000365	0.000638	CcSEcCtD
Eszopiclone—Epistaxis—Epirubicin—urinary bladder cancer	0.000365	0.000637	CcSEcCtD
Eszopiclone—Pruritus—Gemcitabine—urinary bladder cancer	0.000365	0.000636	CcSEcCtD
Eszopiclone—Nausea—Thiotepa—urinary bladder cancer	0.000364	0.000635	CcSEcCtD
Eszopiclone—Weight decreased—Doxorubicin—urinary bladder cancer	0.000363	0.000634	CcSEcCtD
Eszopiclone—Feeling abnormal—Etoposide—urinary bladder cancer	0.000363	0.000633	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.00036	0.000628	CcSEcCtD
Eszopiclone—Pruritus—Fluorouracil—urinary bladder cancer	0.000359	0.000626	CcSEcCtD
Eszopiclone—Drowsiness—Doxorubicin—urinary bladder cancer	0.000358	0.000625	CcSEcCtD
Eszopiclone—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000354	0.000618	CcSEcCtD
Eszopiclone—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000353	0.000616	CcSEcCtD
Eszopiclone—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000351	0.000612	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.000351	0.000612	CcSEcCtD
Eszopiclone—Urticaria—Etoposide—urinary bladder cancer	0.00035	0.00061	CcSEcCtD
Eszopiclone—Stomatitis—Doxorubicin—urinary bladder cancer	0.000349	0.000609	CcSEcCtD
Eszopiclone—Rhinitis—Epirubicin—urinary bladder cancer	0.000348	0.000608	CcSEcCtD
Eszopiclone—Body temperature increased—Etoposide—urinary bladder cancer	0.000348	0.000607	CcSEcCtD
Eszopiclone—Abdominal pain—Etoposide—urinary bladder cancer	0.000348	0.000607	CcSEcCtD
Eszopiclone—Conjunctivitis—Doxorubicin—urinary bladder cancer	0.000348	0.000607	CcSEcCtD
Eszopiclone—Urinary tract infection—Doxorubicin—urinary bladder cancer	0.000348	0.000607	CcSEcCtD
Eszopiclone—Hepatitis—Epirubicin—urinary bladder cancer	0.000347	0.000606	CcSEcCtD
Eszopiclone—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000347	0.000605	CcSEcCtD
Eszopiclone—Tinnitus—Methotrexate—urinary bladder cancer	0.000346	0.000604	CcSEcCtD
Eszopiclone—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000346	0.000603	CcSEcCtD
Eszopiclone—Asthenia—Cisplatin—urinary bladder cancer	0.000345	0.000602	CcSEcCtD
Eszopiclone—Pharyngitis—Epirubicin—urinary bladder cancer	0.000345	0.000602	CcSEcCtD
Eszopiclone—Sweating—Doxorubicin—urinary bladder cancer	0.000343	0.000599	CcSEcCtD
Eszopiclone—Oedema peripheral—Epirubicin—urinary bladder cancer	0.000342	0.000597	CcSEcCtD
Eszopiclone—Haematuria—Doxorubicin—urinary bladder cancer	0.000341	0.000596	CcSEcCtD
Eszopiclone—Epistaxis—Doxorubicin—urinary bladder cancer	0.000338	0.000589	CcSEcCtD
Eszopiclone—Dizziness—Fluorouracil—urinary bladder cancer	0.000335	0.000585	CcSEcCtD
Eszopiclone—Chills—Methotrexate—urinary bladder cancer	0.000333	0.000581	CcSEcCtD
Eszopiclone—Diarrhoea—Cisplatin—urinary bladder cancer	0.000329	0.000574	CcSEcCtD
Eszopiclone—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000328	0.000573	CcSEcCtD
Eszopiclone—Alopecia—Methotrexate—urinary bladder cancer	0.000328	0.000572	CcSEcCtD
Eszopiclone—Vomiting—Gemcitabine—urinary bladder cancer	0.000328	0.000572	CcSEcCtD
Eszopiclone—Rash—Gemcitabine—urinary bladder cancer	0.000325	0.000567	CcSEcCtD
Eszopiclone—Dermatitis—Gemcitabine—urinary bladder cancer	0.000325	0.000567	CcSEcCtD
Eszopiclone—Hypersensitivity—Etoposide—urinary bladder cancer	0.000324	0.000566	CcSEcCtD
Eszopiclone—Tinnitus—Epirubicin—urinary bladder cancer	0.000324	0.000565	CcSEcCtD
Eszopiclone—Headache—Gemcitabine—urinary bladder cancer	0.000323	0.000564	CcSEcCtD
Eszopiclone—Vomiting—Fluorouracil—urinary bladder cancer	0.000322	0.000562	CcSEcCtD
Eszopiclone—Rhinitis—Doxorubicin—urinary bladder cancer	0.000322	0.000562	CcSEcCtD
Eszopiclone—Hepatitis—Doxorubicin—urinary bladder cancer	0.000321	0.000561	CcSEcCtD
Eszopiclone—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.00032	0.000558	CcSEcCtD
Eszopiclone—Rash—Fluorouracil—urinary bladder cancer	0.00032	0.000558	CcSEcCtD
Eszopiclone—Dermatitis—Fluorouracil—urinary bladder cancer	0.000319	0.000557	CcSEcCtD
Eszopiclone—Pharyngitis—Doxorubicin—urinary bladder cancer	0.000319	0.000557	CcSEcCtD
Eszopiclone—Headache—Fluorouracil—urinary bladder cancer	0.000318	0.000554	CcSEcCtD
Eszopiclone—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000317	0.000552	CcSEcCtD
Eszopiclone—Dysgeusia—Methotrexate—urinary bladder cancer	0.000316	0.000552	CcSEcCtD
Eszopiclone—Asthenia—Etoposide—urinary bladder cancer	0.000316	0.000551	CcSEcCtD
Eszopiclone—Back pain—Methotrexate—urinary bladder cancer	0.000313	0.000545	CcSEcCtD
Eszopiclone—Chills—Epirubicin—urinary bladder cancer	0.000312	0.000544	CcSEcCtD
Eszopiclone—Pruritus—Etoposide—urinary bladder cancer	0.000311	0.000543	CcSEcCtD
Eszopiclone—Alopecia—Epirubicin—urinary bladder cancer	0.000307	0.000536	CcSEcCtD
Eszopiclone—Nausea—Gemcitabine—urinary bladder cancer	0.000306	0.000534	CcSEcCtD
Eszopiclone—Vomiting—Cisplatin—urinary bladder cancer	0.000306	0.000533	CcSEcCtD
Eszopiclone—Vision blurred—Methotrexate—urinary bladder cancer	0.000305	0.000531	CcSEcCtD
Eszopiclone—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000304	0.00053	CcSEcCtD
Eszopiclone—Rash—Cisplatin—urinary bladder cancer	0.000303	0.000529	CcSEcCtD
Eszopiclone—Dermatitis—Cisplatin—urinary bladder cancer	0.000303	0.000528	CcSEcCtD
Eszopiclone—Diarrhoea—Etoposide—urinary bladder cancer	0.000301	0.000526	CcSEcCtD
Eszopiclone—Nausea—Fluorouracil—urinary bladder cancer	0.000301	0.000525	CcSEcCtD
Eszopiclone—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.0003	0.000523	CcSEcCtD
Eszopiclone—Tinnitus—Doxorubicin—urinary bladder cancer	0.0003	0.000523	CcSEcCtD
Eszopiclone—Anaemia—Methotrexate—urinary bladder cancer	0.000299	0.000521	CcSEcCtD
Eszopiclone—Tension—Epirubicin—urinary bladder cancer	0.000297	0.000518	CcSEcCtD
Eszopiclone—PTGS1—lymph node—urinary bladder cancer	0.000296	0.0119	CbGeAlD
Eszopiclone—Dysgeusia—Epirubicin—urinary bladder cancer	0.000296	0.000517	CcSEcCtD
Eszopiclone—Nervousness—Epirubicin—urinary bladder cancer	0.000294	0.000512	CcSEcCtD
Eszopiclone—Back pain—Epirubicin—urinary bladder cancer	0.000293	0.00051	CcSEcCtD
Eszopiclone—Malaise—Methotrexate—urinary bladder cancer	0.000291	0.000508	CcSEcCtD
Eszopiclone—Dizziness—Etoposide—urinary bladder cancer	0.000291	0.000508	CcSEcCtD
Eszopiclone—Muscle spasms—Epirubicin—urinary bladder cancer	0.000291	0.000507	CcSEcCtD
Eszopiclone—Vertigo—Methotrexate—urinary bladder cancer	0.00029	0.000507	CcSEcCtD
Eszopiclone—Chills—Doxorubicin—urinary bladder cancer	0.000288	0.000503	CcSEcCtD
Eszopiclone—Nausea—Cisplatin—urinary bladder cancer	0.000285	0.000498	CcSEcCtD
Eszopiclone—Vision blurred—Epirubicin—urinary bladder cancer	0.000285	0.000497	CcSEcCtD
Eszopiclone—Alopecia—Doxorubicin—urinary bladder cancer	0.000284	0.000496	CcSEcCtD
Eszopiclone—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000281	0.00049	CcSEcCtD
Eszopiclone—Convulsion—Methotrexate—urinary bladder cancer	0.00028	0.000488	CcSEcCtD
Eszopiclone—Vomiting—Etoposide—urinary bladder cancer	0.00028	0.000488	CcSEcCtD
Eszopiclone—Anaemia—Epirubicin—urinary bladder cancer	0.000279	0.000488	CcSEcCtD
Eszopiclone—Agitation—Epirubicin—urinary bladder cancer	0.000278	0.000485	CcSEcCtD
Eszopiclone—Rash—Etoposide—urinary bladder cancer	0.000278	0.000484	CcSEcCtD
Eszopiclone—Dermatitis—Etoposide—urinary bladder cancer	0.000277	0.000484	CcSEcCtD
Eszopiclone—Headache—Etoposide—urinary bladder cancer	0.000276	0.000481	CcSEcCtD
Eszopiclone—Chest pain—Methotrexate—urinary bladder cancer	0.000275	0.00048	CcSEcCtD
Eszopiclone—Myalgia—Methotrexate—urinary bladder cancer	0.000275	0.00048	CcSEcCtD
Eszopiclone—Tension—Doxorubicin—urinary bladder cancer	0.000275	0.000479	CcSEcCtD
Eszopiclone—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000274	0.000478	CcSEcCtD
Eszopiclone—Malaise—Epirubicin—urinary bladder cancer	0.000273	0.000476	CcSEcCtD
Eszopiclone—Discomfort—Methotrexate—urinary bladder cancer	0.000272	0.000474	CcSEcCtD
Eszopiclone—Nervousness—Doxorubicin—urinary bladder cancer	0.000272	0.000474	CcSEcCtD
Eszopiclone—Vertigo—Epirubicin—urinary bladder cancer	0.000272	0.000474	CcSEcCtD
Eszopiclone—Back pain—Doxorubicin—urinary bladder cancer	0.000271	0.000472	CcSEcCtD
Eszopiclone—Muscle spasms—Doxorubicin—urinary bladder cancer	0.000269	0.000469	CcSEcCtD
Eszopiclone—Palpitations—Epirubicin—urinary bladder cancer	0.000267	0.000466	CcSEcCtD
Eszopiclone—Confusional state—Methotrexate—urinary bladder cancer	0.000266	0.000464	CcSEcCtD
Eszopiclone—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000264	0.00046	CcSEcCtD
Eszopiclone—Vision blurred—Doxorubicin—urinary bladder cancer	0.000264	0.00046	CcSEcCtD
Eszopiclone—Convulsion—Epirubicin—urinary bladder cancer	0.000262	0.000457	CcSEcCtD
Eszopiclone—Infection—Methotrexate—urinary bladder cancer	0.000262	0.000457	CcSEcCtD
Eszopiclone—Nausea—Etoposide—urinary bladder cancer	0.000262	0.000456	CcSEcCtD
Eszopiclone—Hypertension—Epirubicin—urinary bladder cancer	0.000261	0.000456	CcSEcCtD
Eszopiclone—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.00026	0.000453	CcSEcCtD
Eszopiclone—Anaemia—Doxorubicin—urinary bladder cancer	0.000259	0.000451	CcSEcCtD
Eszopiclone—Chest pain—Epirubicin—urinary bladder cancer	0.000257	0.000449	CcSEcCtD
Eszopiclone—Myalgia—Epirubicin—urinary bladder cancer	0.000257	0.000449	CcSEcCtD
Eszopiclone—Agitation—Doxorubicin—urinary bladder cancer	0.000257	0.000449	CcSEcCtD
Eszopiclone—Anxiety—Epirubicin—urinary bladder cancer	0.000257	0.000448	CcSEcCtD
Eszopiclone—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000255	0.000445	CcSEcCtD
Eszopiclone—Discomfort—Epirubicin—urinary bladder cancer	0.000254	0.000444	CcSEcCtD
Eszopiclone—Malaise—Doxorubicin—urinary bladder cancer	0.000252	0.00044	CcSEcCtD
Eszopiclone—Dry mouth—Epirubicin—urinary bladder cancer	0.000252	0.000439	CcSEcCtD
Eszopiclone—Vertigo—Doxorubicin—urinary bladder cancer	0.000251	0.000439	CcSEcCtD
Eszopiclone—Anorexia—Methotrexate—urinary bladder cancer	0.000251	0.000439	CcSEcCtD
Eszopiclone—Confusional state—Epirubicin—urinary bladder cancer	0.000249	0.000434	CcSEcCtD
Eszopiclone—Palpitations—Doxorubicin—urinary bladder cancer	0.000247	0.000431	CcSEcCtD
Eszopiclone—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000247	0.000431	CcSEcCtD
Eszopiclone—Infection—Epirubicin—urinary bladder cancer	0.000245	0.000428	CcSEcCtD
Eszopiclone—Convulsion—Doxorubicin—urinary bladder cancer	0.000242	0.000423	CcSEcCtD
Eszopiclone—Hypertension—Doxorubicin—urinary bladder cancer	0.000242	0.000421	CcSEcCtD
Eszopiclone—Tachycardia—Epirubicin—urinary bladder cancer	0.000241	0.00042	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00024	0.000419	CcSEcCtD
Eszopiclone—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000239	0.000416	CcSEcCtD
Eszopiclone—Insomnia—Methotrexate—urinary bladder cancer	0.000239	0.000416	CcSEcCtD
Eszopiclone—Chest pain—Doxorubicin—urinary bladder cancer	0.000238	0.000416	CcSEcCtD
Eszopiclone—Myalgia—Doxorubicin—urinary bladder cancer	0.000238	0.000416	CcSEcCtD
Eszopiclone—Anxiety—Doxorubicin—urinary bladder cancer	0.000237	0.000414	CcSEcCtD
Eszopiclone—Paraesthesia—Methotrexate—urinary bladder cancer	0.000237	0.000413	CcSEcCtD
Eszopiclone—Discomfort—Doxorubicin—urinary bladder cancer	0.000235	0.000411	CcSEcCtD
Eszopiclone—Anorexia—Epirubicin—urinary bladder cancer	0.000235	0.00041	CcSEcCtD
Eszopiclone—Dyspnoea—Methotrexate—urinary bladder cancer	0.000235	0.00041	CcSEcCtD
Eszopiclone—Somnolence—Methotrexate—urinary bladder cancer	0.000234	0.000409	CcSEcCtD
Eszopiclone—Dry mouth—Doxorubicin—urinary bladder cancer	0.000233	0.000406	CcSEcCtD
Eszopiclone—Dyspepsia—Methotrexate—urinary bladder cancer	0.000232	0.000405	CcSEcCtD
Eszopiclone—Confusional state—Doxorubicin—urinary bladder cancer	0.00023	0.000402	CcSEcCtD
Eszopiclone—Decreased appetite—Methotrexate—urinary bladder cancer	0.000229	0.0004	CcSEcCtD
Eszopiclone—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000228	0.000398	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000228	0.000397	CcSEcCtD
Eszopiclone—Fatigue—Methotrexate—urinary bladder cancer	0.000227	0.000397	CcSEcCtD
Eszopiclone—Infection—Doxorubicin—urinary bladder cancer	0.000227	0.000396	CcSEcCtD
Eszopiclone—Pain—Methotrexate—urinary bladder cancer	0.000226	0.000393	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000225	0.000392	CcSEcCtD
Eszopiclone—Insomnia—Epirubicin—urinary bladder cancer	0.000223	0.000389	CcSEcCtD
Eszopiclone—Tachycardia—Doxorubicin—urinary bladder cancer	0.000223	0.000389	CcSEcCtD
Eszopiclone—Paraesthesia—Epirubicin—urinary bladder cancer	0.000222	0.000387	CcSEcCtD
Eszopiclone—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000221	0.000385	CcSEcCtD
Eszopiclone—Dyspnoea—Epirubicin—urinary bladder cancer	0.00022	0.000384	CcSEcCtD
Eszopiclone—Somnolence—Epirubicin—urinary bladder cancer	0.000219	0.000383	CcSEcCtD
Eszopiclone—Anorexia—Doxorubicin—urinary bladder cancer	0.000218	0.00038	CcSEcCtD
Eszopiclone—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000217	0.000379	CcSEcCtD
Eszopiclone—Dyspepsia—Epirubicin—urinary bladder cancer	0.000217	0.000379	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000216	0.000376	CcSEcCtD
Eszopiclone—Decreased appetite—Epirubicin—urinary bladder cancer	0.000215	0.000374	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000213	0.000372	CcSEcCtD
Eszopiclone—Fatigue—Epirubicin—urinary bladder cancer	0.000213	0.000371	CcSEcCtD
Eszopiclone—Constipation—Epirubicin—urinary bladder cancer	0.000211	0.000368	CcSEcCtD
Eszopiclone—Pain—Epirubicin—urinary bladder cancer	0.000211	0.000368	CcSEcCtD
Eszopiclone—Urticaria—Methotrexate—urinary bladder cancer	0.00021	0.000366	CcSEcCtD
Eszopiclone—Abdominal pain—Methotrexate—urinary bladder cancer	0.000208	0.000364	CcSEcCtD
Eszopiclone—Body temperature increased—Methotrexate—urinary bladder cancer	0.000208	0.000364	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000208	0.000363	CcSEcCtD
Eszopiclone—Insomnia—Doxorubicin—urinary bladder cancer	0.000207	0.00036	CcSEcCtD
Eszopiclone—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000205	0.000358	CcSEcCtD
Eszopiclone—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000204	0.000355	CcSEcCtD
Eszopiclone—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000203	0.000355	CcSEcCtD
Eszopiclone—Somnolence—Doxorubicin—urinary bladder cancer	0.000203	0.000354	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000202	0.000352	CcSEcCtD
Eszopiclone—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000201	0.000351	CcSEcCtD
Eszopiclone—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000199	0.000346	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000197	0.000344	CcSEcCtD
Eszopiclone—Fatigue—Doxorubicin—urinary bladder cancer	0.000197	0.000344	CcSEcCtD
Eszopiclone—Urticaria—Epirubicin—urinary bladder cancer	0.000196	0.000342	CcSEcCtD
Eszopiclone—Pain—Doxorubicin—urinary bladder cancer	0.000195	0.000341	CcSEcCtD
Eszopiclone—Constipation—Doxorubicin—urinary bladder cancer	0.000195	0.000341	CcSEcCtD
Eszopiclone—Abdominal pain—Epirubicin—urinary bladder cancer	0.000195	0.00034	CcSEcCtD
Eszopiclone—Body temperature increased—Epirubicin—urinary bladder cancer	0.000195	0.00034	CcSEcCtD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000195	0.00381	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000194	0.000339	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000192	0.00376	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00019	0.00373	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—HPGDS—urinary bladder cancer	0.00019	0.00371	CbGpPWpGaD
Eszopiclone—Asthenia—Methotrexate—urinary bladder cancer	0.000189	0.00033	CcSEcCtD
Eszopiclone—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000188	0.000328	CcSEcCtD
Eszopiclone—CYP2C9—Biological oxidations—CYP4B1—urinary bladder cancer	0.000187	0.00367	CbGpPWpGaD
Eszopiclone—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000187	0.000326	CcSEcCtD
Eszopiclone—Pruritus—Methotrexate—urinary bladder cancer	0.000187	0.000326	CcSEcCtD
Eszopiclone—GABRA4—Orphan transporters—CREBBP—urinary bladder cancer	0.000185	0.00363	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000185	0.00362	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000184	0.00361	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTT1—urinary bladder cancer	0.000184	0.0036	CbGpPWpGaD
Eszopiclone—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000182	0.000317	CcSEcCtD
Eszopiclone—Urticaria—Doxorubicin—urinary bladder cancer	0.000181	0.000317	CcSEcCtD
Eszopiclone—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000181	0.000315	CcSEcCtD
Eszopiclone—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000181	0.000315	CcSEcCtD
Eszopiclone—Diarrhoea—Methotrexate—urinary bladder cancer	0.00018	0.000315	CcSEcCtD
Eszopiclone—PTGS1—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000177	0.00348	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000177	0.00347	CbGpPWpGaD
Eszopiclone—Asthenia—Epirubicin—urinary bladder cancer	0.000177	0.000309	CcSEcCtD
Eszopiclone—PTGS1—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000177	0.00347	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000175	0.00344	CbGpPWpGaD
Eszopiclone—Pruritus—Epirubicin—urinary bladder cancer	0.000175	0.000305	CcSEcCtD
Eszopiclone—Dizziness—Methotrexate—urinary bladder cancer	0.000174	0.000304	CcSEcCtD
Eszopiclone—GABRB2—Orphan transporters—CREBBP—urinary bladder cancer	0.000169	0.00332	CbGpPWpGaD
Eszopiclone—Diarrhoea—Epirubicin—urinary bladder cancer	0.000169	0.000295	CcSEcCtD
Eszopiclone—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000168	0.000294	CcSEcCtD
Eszopiclone—Vomiting—Methotrexate—urinary bladder cancer	0.000168	0.000293	CcSEcCtD
Eszopiclone—Rash—Methotrexate—urinary bladder cancer	0.000166	0.00029	CcSEcCtD
Eszopiclone—Dermatitis—Methotrexate—urinary bladder cancer	0.000166	0.00029	CcSEcCtD
Eszopiclone—Headache—Methotrexate—urinary bladder cancer	0.000165	0.000288	CcSEcCtD
Eszopiclone—GABRA5—Orphan transporters—CREBBP—urinary bladder cancer	0.000164	0.00322	CbGpPWpGaD
Eszopiclone—Asthenia—Doxorubicin—urinary bladder cancer	0.000164	0.000286	CcSEcCtD
Eszopiclone—Dizziness—Epirubicin—urinary bladder cancer	0.000163	0.000285	CcSEcCtD
Eszopiclone—Pruritus—Doxorubicin—urinary bladder cancer	0.000162	0.000282	CcSEcCtD
Eszopiclone—GABRA3—Orphan transporters—CREBBP—urinary bladder cancer	0.000161	0.00316	CbGpPWpGaD
Eszopiclone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000161	0.00316	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00016	0.00314	CbGpPWpGaD
Eszopiclone—GABRA2—Orphan transporters—CREBBP—urinary bladder cancer	0.000159	0.00311	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—GPX1—urinary bladder cancer	0.000158	0.0031	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000158	0.0031	CbGpPWpGaD
Eszopiclone—Vomiting—Epirubicin—urinary bladder cancer	0.000157	0.000274	CcSEcCtD
Eszopiclone—Nausea—Methotrexate—urinary bladder cancer	0.000157	0.000273	CcSEcCtD
Eszopiclone—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000156	0.000273	CcSEcCtD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000156	0.00306	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000156	0.00305	CbGpPWpGaD
Eszopiclone—Rash—Epirubicin—urinary bladder cancer	0.000156	0.000272	CcSEcCtD
Eszopiclone—Dermatitis—Epirubicin—urinary bladder cancer	0.000155	0.000271	CcSEcCtD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000155	0.00304	CbGpPWpGaD
Eszopiclone—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	0.000155	0.00303	CbGpPWpGaD
Eszopiclone—Headache—Epirubicin—urinary bladder cancer	0.000155	0.00027	CcSEcCtD
Eszopiclone—CYP2C8—Biological oxidations—NAT2—urinary bladder cancer	0.000153	0.003	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000153	0.003	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000151	0.00296	CbGpPWpGaD
Eszopiclone—Dizziness—Doxorubicin—urinary bladder cancer	0.000151	0.000263	CcSEcCtD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.00015	0.00295	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.00015	0.00294	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.00015	0.00294	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000148	0.0029	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000147	0.00287	CbGpPWpGaD
Eszopiclone—Nausea—Epirubicin—urinary bladder cancer	0.000147	0.000256	CcSEcCtD
Eszopiclone—Vomiting—Doxorubicin—urinary bladder cancer	0.000145	0.000253	CcSEcCtD
Eszopiclone—Rash—Doxorubicin—urinary bladder cancer	0.000144	0.000251	CcSEcCtD
Eszopiclone—Dermatitis—Doxorubicin—urinary bladder cancer	0.000144	0.000251	CcSEcCtD
Eszopiclone—Headache—Doxorubicin—urinary bladder cancer	0.000143	0.00025	CcSEcCtD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000143	0.0028	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000137	0.00269	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	0.000137	0.00268	CbGpPWpGaD
Eszopiclone—Nausea—Doxorubicin—urinary bladder cancer	0.000136	0.000237	CcSEcCtD
Eszopiclone—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.000135	0.00265	CbGpPWpGaD
Eszopiclone—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000135	0.00265	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000131	0.00256	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000128	0.00251	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTP1—urinary bladder cancer	0.000127	0.0025	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000127	0.00249	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000125	0.00244	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—NAT2—urinary bladder cancer	0.000125	0.00244	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000124	0.00242	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000123	0.00241	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000123	0.0024	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—HPGDS—urinary bladder cancer	0.000122	0.0024	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000122	0.00239	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00012	0.00234	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTT1—urinary bladder cancer	0.000119	0.00233	CbGpPWpGaD
Eszopiclone—PTGS1—Biological oxidations—GSTM1—urinary bladder cancer	0.000117	0.0023	CbGpPWpGaD
Eszopiclone—CYP2C8—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	0.000115	0.00225	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	0.000113	0.00221	CbGpPWpGaD
Eszopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000106	0.00209	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000105	0.00206	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000104	0.00205	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—HPGDS—urinary bladder cancer	9.96e-05	0.00195	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.78e-05	0.00192	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTT1—urinary bladder cancer	9.66e-05	0.00189	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.65e-05	0.00189	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—urinary bladder cancer	9.32e-05	0.00183	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.84e-05	0.00173	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.83e-05	0.00173	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.58e-05	0.00168	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.42e-05	0.00165	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.28e-05	0.00162	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—urinary bladder cancer	8.23e-05	0.00161	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	8.22e-05	0.00161	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.12e-05	0.00159	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	8.11e-05	0.00159	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.07e-05	0.00158	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTZ1—urinary bladder cancer	7.81e-05	0.00153	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.77e-05	0.00152	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—TNF—urinary bladder cancer	7.62e-05	0.00149	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTM1—urinary bladder cancer	7.56e-05	0.00148	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.46e-05	0.00146	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTO2—urinary bladder cancer	7.4e-05	0.00145	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NAT1—urinary bladder cancer	7.4e-05	0.00145	CbGpPWpGaD
Eszopiclone—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.39e-05	0.00145	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.28e-05	0.00143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	7.19e-05	0.00141	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.06e-05	0.00138	CbGpPWpGaD
Eszopiclone—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.8e-05	0.00133	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—UGT2B7—urinary bladder cancer	6.77e-05	0.00133	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—urinary bladder cancer	6.7e-05	0.00131	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.66e-05	0.00131	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—urinary bladder cancer	6.61e-05	0.00129	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	6.57e-05	0.00129	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	6.37e-05	0.00125	CbGpPWpGaD
Eszopiclone—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.22e-05	0.00122	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTM1—urinary bladder cancer	6.16e-05	0.00121	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP4B1—urinary bladder cancer	6.09e-05	0.00119	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTM1—urinary bladder cancer	6.07e-05	0.00119	CbGpPWpGaD
Eszopiclone—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.04e-05	0.00118	CbGpPWpGaD
Eszopiclone—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.93e-05	0.00116	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.83e-05	0.00114	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC19A1—urinary bladder cancer	5.75e-05	0.00113	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.69e-05	0.00111	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PRSS3—urinary bladder cancer	5.61e-05	0.0011	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.55e-05	0.00109	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.41e-05	0.00106	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.11e-05	0.001	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	5.04e-05	0.000988	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.97e-05	0.000974	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.91e-05	0.000962	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	4.78e-05	0.000937	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NAT1—urinary bladder cancer	4.78e-05	0.000937	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.7e-05	0.000921	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.67e-05	0.000916	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.54e-05	0.00089	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.52e-05	0.000885	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.5e-05	0.000881	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TYMP—urinary bladder cancer	4.48e-05	0.000879	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.46e-05	0.000874	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	4.42e-05	0.000866	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.38e-05	0.000859	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	4.37e-05	0.000857	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	4.36e-05	0.000854	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.31e-05	0.000844	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.27e-05	0.000838	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—HRAS—urinary bladder cancer	4.25e-05	0.000834	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.13e-05	0.00081	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	4.1e-05	0.000804	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.06e-05	0.000796	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NAT2—urinary bladder cancer	4.05e-05	0.000795	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.01e-05	0.000787	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4e-05	0.000785	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.94e-05	0.000772	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	3.94e-05	0.000771	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—HRAS—urinary bladder cancer	3.92e-05	0.000767	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	3.89e-05	0.000762	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NAT1—urinary bladder cancer	3.89e-05	0.000762	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.87e-05	0.000759	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	3.83e-05	0.00075	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.78e-05	0.000741	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.74e-05	0.000732	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	3.72e-05	0.000729	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	3.62e-05	0.00071	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—HRAS—urinary bladder cancer	3.58e-05	0.000702	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	3.56e-05	0.000697	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—RRM2—urinary bladder cancer	3.5e-05	0.000686	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—HRAS—urinary bladder cancer	3.48e-05	0.000682	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—HRAS—urinary bladder cancer	3.42e-05	0.00067	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—HRAS—urinary bladder cancer	3.36e-05	0.000658	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.3e-05	0.000647	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—HRAS—urinary bladder cancer	3.28e-05	0.000642	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—HPGDS—urinary bladder cancer	3.24e-05	0.000635	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ENO2—urinary bladder cancer	3.24e-05	0.000635	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.22e-05	0.000632	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	3.2e-05	0.000628	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTT1—urinary bladder cancer	3.14e-05	0.000616	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.1e-05	0.000607	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	3.03e-05	0.000593	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	2.95e-05	0.000578	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.9e-05	0.000569	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TYMP—urinary bladder cancer	2.9e-05	0.000568	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—HRAS—urinary bladder cancer	2.86e-05	0.000561	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.78e-05	0.000545	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	2.71e-05	0.00053	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NAT2—urinary bladder cancer	2.62e-05	0.000513	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NQO1—urinary bladder cancer	2.61e-05	0.000512	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	2.57e-05	0.000503	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NAT1—urinary bladder cancer	2.57e-05	0.000503	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.53e-05	0.000497	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.36e-05	0.000463	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TYMP—urinary bladder cancer	2.36e-05	0.000462	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.35e-05	0.00046	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.26e-05	0.000444	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—RRM2—urinary bladder cancer	2.26e-05	0.000443	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.21e-05	0.000433	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—urinary bladder cancer	2.18e-05	0.000427	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NAT2—urinary bladder cancer	2.13e-05	0.000418	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.11e-05	0.000414	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.11e-05	0.000413	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ENO2—urinary bladder cancer	2.09e-05	0.00041	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	2.09e-05	0.00041	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.08e-05	0.000408	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	2.03e-05	0.000398	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—TYMS—urinary bladder cancer	2.03e-05	0.000397	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTM1—urinary bladder cancer	2e-05	0.000392	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOR1—urinary bladder cancer	2e-05	0.000392	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2e-05	0.000392	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2e-05	0.000391	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.94e-05	0.000381	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GPX1—urinary bladder cancer	1.92e-05	0.000376	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ERCC2—urinary bladder cancer	1.88e-05	0.000369	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.84e-05	0.000361	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—MTHFR—urinary bladder cancer	1.77e-05	0.000347	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.7e-05	0.000334	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.7e-05	0.000334	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.69e-05	0.000332	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.69e-05	0.000331	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.65e-05	0.000324	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.64e-05	0.000321	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.63e-05	0.000319	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.55e-05	0.000305	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARG—urinary bladder cancer	1.44e-05	0.000281	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.43e-05	0.00028	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.41e-05	0.000276	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.41e-05	0.000276	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CREBBP—urinary bladder cancer	1.38e-05	0.00027	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.37e-05	0.000269	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.36e-05	0.000267	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.33e-05	0.000261	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.31e-05	0.000256	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.29e-05	0.000254	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.29e-05	0.000254	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.24e-05	0.000243	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	0.000238	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.21e-05	0.000238	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.16e-05	0.000228	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.15e-05	0.000225	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.14e-05	0.000224	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—urinary bladder cancer	1.13e-05	0.000221	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.12e-05	0.00022	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.12e-05	0.00022	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.11e-05	0.000217	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.09e-05	0.000214	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.07e-05	0.000209	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.05e-05	0.000206	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.05e-05	0.000206	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.01e-05	0.000198	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	9.9e-06	0.000194	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—urinary bladder cancer	9.85e-06	0.000193	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—EP300—urinary bladder cancer	9.39e-06	0.000184	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	9.3e-06	0.000182	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARG—urinary bladder cancer	9.27e-06	0.000182	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NQO1—urinary bladder cancer	9.06e-06	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	8.9e-06	0.000175	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	7.56e-06	0.000148	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARG—urinary bladder cancer	7.54e-06	0.000148	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	7.29e-06	0.000143	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	7.25e-06	0.000142	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—TYMS—urinary bladder cancer	7.02e-06	0.000138	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.94e-06	0.000136	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.94e-06	0.000136	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GPX1—urinary bladder cancer	6.65e-06	0.00013	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	6.53e-06	0.000128	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—urinary bladder cancer	6.36e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	6.14e-06	0.00012	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—EP300—urinary bladder cancer	6.06e-06	0.000119	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.93e-06	0.000116	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—urinary bladder cancer	5.18e-06	0.000101	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.98e-06	9.75e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.94e-06	9.67e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.78e-06	9.37e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.91e-06	7.67e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.41e-06	6.69e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.26e-06	6.38e-05	CbGpPWpGaD
